Chembond Material Technologies Limited (CHEMBOND) — Announcement | 17 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
NRC approves grant of 50,738 stock options under ESOP 2025
💡 Investor Takeaway
Shareholders should note this dilutive grant may affect future earnings per share and stock performance.

Chembond Material Technologies Limited announced on July 17, 2026 that its Nomination and Remuneration Committee approved the grant of 50,738 stock options under the Employee Stock Option Plan 2025, with an exercise price of ₹171 per share convertible into fully paid equity shares of ₹5 face value, vesting over a maximum five-year period with a one-year minimum gap.

📄 View Original Announcement (PDF)

About Chembond Material Technologies Limited (CHEMBOND)

Chemicals · Chemicals · Listed on NSE

Market Cap: ₹229.76 Cr P/E: 15.7 ROE: 8.8% ROCE: 9.6% Div Yield: 1.17%

View full CHEMBOND stock details →

📡 Get AI alerts when CHEMBOND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CHEMBOND — Free

📊 More CHEMBOND filings

See all CHEMBOND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CHEMBOND files new disclosures

Track CHEMBOND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CHEMBOND — Free

Free account · 2 AI queries/day